Characterization of a Novel Hyperthermophilic GH1 β-Glucosidase from Acidilobus sp. and Its Application in the Hydrolysis of Soybean Isoflavone Glycosides.
Jinjian HeYuying LiXihang SunDinghui ZuoMansheng WangXia ZhengPinglian YuPengjun ShiPublished in: Microorganisms (2024)
A putative β-glucosidase gene, BglAc , was amplified from Acidilobus sp. through metagenome database sampling from a hot spring in Yellowstone National Park. BglAc is composed of 485 amino acid residues and bioinformatics analysis showed that it belongs to the GH1 family of β-glucosidases. The gene was successfully expressed in Escherichia coli with a molecular weight of approximately 55.3 kDa. The purified recombinant enzyme showed the maximum activity using p -nitrophenyl-β-D-glucopyranoside ( p NPG) as the substrate at optimal pH 5.0 and 100 °C. BglAc exhibited extraordinary thermostability, and its half-life at 90 °C was 6 h. The specific activity, K m , V max , and K cat / K m of BglAc toward p NPG were 357.62 U mg -1 , 3.41 mM, 474.0 μmol min -1 ·mg -1 , and 122.7 s -1 mM -1 . BglAc exhibited the characteristic of glucose tolerance, and the inhibition constant K i was 180.0 mM. Furthermore, a significant ethanol tolerance was observed, retaining 96% relative activity at 10% ethanol, and even 78% at 20% ethanol, suggesting BglAc as a promising enzyme for cellulose saccharification. BglAc also had a strong ability to convert the major soybean isoflavone glycosides (daidzin, genistin, and glycitin) into their corresponding aglycones. Overall, BglAc was actually a new β-glucosidase with excellent thermostability, ethanol tolerance, and glycoside hydrolysis ability, indicating its wide prospects for applications in the food industry, animal feed, and lignocellulosic biomass degradation.
Keyphrases
- escherichia coli
- molecular docking
- anaerobic digestion
- amino acid
- copy number
- genome wide
- bioinformatics analysis
- emergency department
- risk assessment
- gene expression
- quality improvement
- growth hormone
- ionic liquid
- transcription factor
- cystic fibrosis
- human health
- climate change
- multidrug resistant
- silver nanoparticles
- aqueous solution